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Calcium phosphate (CaP) substrates are successfully used as a bone grafts due to their 
osteogenic properties. However, the influence of the physicochemical features of CaPs in 
angiogenesis is frequently neglected despite it is a crucial process for bone regeneration. The 
present work focuses on analyzing the effect of textural parameters of biomimetic calcium 
deficient hydroxyapatite (CDHA) and sintered beta-tricalcium phosphate (β-TCP) such as 
specific surface area (SSA), surface roughness and microstructure on the behavior of rat 
endothelial progenitor cells (rEPCs) and their crosstalk with rat mesenchymal stem cells 
(rMSCs). The higher reactivity of CDHA resulted in low proliferation rates in mono- and 




































































with fine microstructure. In terms of angiogenic and osteogenic gene expression, the 
upregulation of particular genes was especially enhanced for needle-like CDHA compared to 
plate-like CDHA and β-TCP suggesting the importance not only of chemistry of substrate but 
also its textural features. Moreover, the coculture of rEPCs and rMSCs on needle-like CDHA 
resulted in early upregulation of osteogenic modulator i.e. protein deglycase 1 (DJ 1) what 
might be a possible cause of overexpression of osteogenic- related genes on the same 
substrate. 
1. Introduction
Bone healing is a complex process that involves multiple interdependent and overlapping-in-
time steps.[1] For instance, the timely angiogenesis serves not only as a source of oxygen and 
nutrients, but also controls the recruitment and differentiation of stem cells, the osteoblastic 
activity and consequently further new bone formation.[2,3] Therefore, the interplay between 
vessel-forming endothelial cells (ECs) and bone-forming cells is critical during the bone 
healing process. The ability of these cells to communicate, both through autocrine/paracrine 
routes and through direct gap junctional cell-to-cell contacts, results in a tight coupling 
between angiogenesis and osteogenesis.[2] For instance, mesenchymal stem cells (MSCs) and 
osteoblasts secrete angiogenic factors such as vascular endothelial growth factor (VEGF),[4] 
fibroblasts growth factor (FGF)[5] and protein deglycase 1 (DJ 1)[6] whose goal is to enhance 
ECs proliferation and subsequent vessel growth. On the other hand, ECs express bone 
morphogenetic protein 2 (BMP-2) and endothelin 1 (EDH 1), which fulfil dual function by 
regulating angiogenesis as well as stimulating bone formation.[7–10] 
Despite the remarkable self-regenerative capacity of bone tissue, large defects cannot be 
bridged unless some support structures, namely bone grafts, are implanted to support the 



































































grafts, due to their close compositional resemblance to the mineral phase of bone. 
Furthermore, some of them such as sintered β-TCP or low temperature CDHA[11,12] were 
reported to possess osteoconductive/osteoinductive properties that might foster the 
osteogenesis-related processes.   
Great efforts have been made in CaPs research towards investigating to which extent and how 
their particular physicochemical features such as macroporosity, chemistry, ionic 
release/uptake, and surface topography affect the osteoinductive/osteoconductive 
potential.[13,14] Nonetheless, since bone healing process is complex, involving not only bone-
forming cells but also immune or endothelial cells, the implant should actively participate in 
the former stages of bone regeneration exhibiting anti-inflammatory and angiogenic 
properties as well as stimulating the proper crosstalk between the different cell types 
implicated in restoring of bone function.  
Recently, some advances have been made in modulating the angiogenic performance of CaP- 
based materials. The macroporosity,[15,16] functionalisation/loading of scaffold with 
biomolecules like RGD[16] or VEGF[17,18] or incorporation of ions like cooper[19] or cobalt[20] 
have been investigated as strategies for potentiating the angiogenic features of CaPs. 
Moreover, the in vitro prevascularisation of bone grafts was also studied as an interesting 
approach for the preparation of constructs with enhanced angiogenic performance. For 
instance, Chen et al. and Thein-Han et al. showed that coculturing of endothelial and bone 
forming cells on microporous calcium phosphate scaffolds had positive impact on stimulating 
the formation of microcapillary network as well as the expression of genes involved in both 
angiogenesis and osteogenesis.[16,21] Although the pathways involved in activation of positive 
crosstalk of endothelial and bone cells have been widely investigated,[22,23] little attention has 
been paid to the effect of particular features of CaPs on the angiogenic and osteogenic events 



































































Therefore, the current study tackles two main goals. The first was to investigate to which 
extent the particular cues of CDHA affect the behaviour of endothelial progenitor and 
mesenchymal stem cells separately. Two chemically identical biomimetic calcium deficient 
hydroxyapatite, consisting of either needle-like or plate-like crystals were compared to 
sintered β-TCP in terms of its effect on rEPCs and rMSCs proliferation, PECAM-1 
production and osteogenic/angiogenic gene expression. As a second goal, the outcome of 
physicochemical features of CaPs on the interaction of rEPCs and rMSCs were investigated 
through coculture system evaluating angiogenic and osteogenic gene expression and the 
secretion of connexin43, a junctional protein responsible for cell-to-cell communication. 
Additionally, the expression of protein deglycase 1 (DJ 1) and endothelin 1 (EDH 1) was 
analysed, as possible mediators of rEPCs and rMScs crosstalk. 
2. Results
2.1. Physicochemical characterization of CaPs 
The XRD diffraction confirmed that CaPs are phase-pure (Figure 1C) except for C-CDHA, 
where traces of unreacted α- TCP were observed (< 3%). The sintered β-TCP showed sharp 
diffraction peaks whilst broad peaks were observed for C-CDHA and especially for F-CDHA 
substrates. Whereas all materials presented similar porosities (Figure 1D), clear differences 
were observed in terms of microstructure. C-CDHA consisted of plate-like crystals, whereas 
F-CDHA presented nanometric sized needle-like crystals, organised in agglomerates. The
sintering process of β-TCP led to the formation of polyhedral crystals (Figure 1A). The 
microstructural differences resulted in higher SSA for the biomimetic CDHA compared to 
sintered β-TCP. C-CDHA presented higher average roughness values than F-CDHA and 



































































2.2. Initial adhesion and proliferation in monocultures and cocultures 
Similar adhesion of monocultured rEPCs was observed in all substrates (Figure 2A). 
Monocultured rEPCs progressively increased their number in all CaPs with slightly slower 
proliferation rate on biomimetic CDHA substrates. Moreover, lower number of monocultured 
rEPCs on β-TCP at day 3 was observed compared to TCPS. 
In monocultured rMSCs, the cellular adhesion was lower on CDHA substrates whilst β-TCP 
presented similar number of adhered cells compared to the control. Overall, the proliferative 
potential of monocultured rMSCs was lower when cultured on CaP substrates. This scenario 
was especially pronounced for biomimetic substrates where the cellular proliferation was 
significantly slowed down or impaired on C-CDHA and F-CDHA, respectively. Moreover, 
the β-TCP showed significantly lower number of monocultured rMSCs at day 21 compared to 
the control. 
In coculture system, the cellular adhesion was also lower on CDHA compared to β-TCP and 
TCPS.  The cells presented low proliferation rate on biomimetic CDHA being this scenario 
especially pronounced on F-CDHA, where similar cell numbers were observed over the cell 
culture times. Nonetheless, the proliferative potential of cells on C-CDHA was higher on 
coculture condition compared to monocultured rMSCs. The enhanced proliferation rate on 
coculture was also observed for β-TCP compared to monocultured rMSCs. 
2.3. Ionic concentration 
The evolution of calcium and phosphate concentration in the EGM-2 MV culture medium in 
presence of cells is displayed in Figure 2B and 3C, respectively. The initial value of Ca2+ 
concentration was 1.89±0.05 mM. In general, irrespective of the cell type, little alteration of 



































































uptook Ca2+ ions from the medium, this resulting in a 20% decrease in calcium concentration 
compared to the control throughout the whole culture period. In rMSCs monoculture, the 
decrease of Ca2+ by F-CDHA was observed at 6 h and 14 d of cell culture whilst this trend for 
coculture was noted at 6 h, 14 and 21 d.  
The initial experimental value of Pi was 1.02±0.01 mM. In general, higher Pi levels were 
detected in presence of the biomimetic substrates, whereas the values registered for the β-TCP 
substrates were similar to TCPS. Despite using the same cell culture medium, different trends 
were observed for the biomimetic substrates depending on cell type. For rEPCs monoculture, 
the CDHA increased approximately 50% the Pi concentration compared to TCPS at 6 hours. 
In contrast, for rMSCs monoculture and coculture on biomimetic CDHA highest levels of Pi 
were observed at day 3, reaching approximately 170% and 130% Pi concentration compared 
to TCPS, respectively. Comparing the two biomimetic substrates, F-CDHA led to more 
pronounced changes of Pi content. In all cell culture conditions on CDHA, slow and 
progressive decrease of Pi concentration was observed after reaching the aforementioned 
highest levels. 
2.4. Cell morphology 
Cellular morphology in mono- and coculture on CaP substrates at 14 and 21 days were 
studied through visualisation with a CLSM. For that purpose, cells were stained for F-actin 
and nuclei (Figure 3). In all conditions, the cells presented a spread morphology with well-
defined cytoskeleton except for monocultured rMSCs on F-CDHA at day 21. 
Cx43, a gap-junction protein, was visualised in all CaP substrates over all cell culture 
conditions at days 14 and 21 (Figure 4). The analysis revealed that Cx43 protein was mainly 



































































in control group. In all conditions the presence of Cx43 was mainly localized in the outer part 
of the cellular membrane. 
In order to distinguish rEPCs at coculture conditions, cells were additionally incubated with 
endothelial specific PECAM-1 and compared to monocultured rEPCs (Figure 5A). Whilst 
PECAM-1 was well visible in rEPCs monoculture, a small number of PECAM-1 positively 
stained cells were observed in coculture. Semiquantitative analysis of CLSM images revealed 
that at day 14 the PECAM-1 stained area in rEPCs monoculture was slightly lower on C-
CDHA and β-TCP sample whilst the F-CDHA showed similar values to that observed on 
control group (Figure 5B). In case of coculture, increased values of PECAM-1 stained area 
were observed for C-CDHA at day 14 (Figure 5C) compared to other CaPs and control. These 
differences between substrates were not statistically significant and they disappeared at day 
21. 
2.6. Gene expression 
2.6.1. Osteogenic gene expression 
The expression of genes related to osteogenesis is depicted in Figure 6. In general, an 
upregulation of the osteogenic genes was detected on the CaP substrates, both in mono- and 
coculture conditions. A considerable upregulation of the ALP expression was observed on the 
F-CDHA substrate, irrespective of cell type. In monocultured rMSCs the maximum value was
attained at day 1, decreasing at 7 and 14 days. In contrast, in monocultured rEPCs and in the 
cocultures the ALP expression increased at 1 and 7 days, strongly decreasing at day 14. The 
expression of BMP-2 was higher for monocultured rEPCs compared to the other culture 
conditions in all substrates at day 1, decreasing afterwards. Conversely, monocultured rMSCs 
and coculture continuously increased their BMP-2 expression until day 7, especially for F-



































































OC expression, it was upregulated at early time points in the rEPCs, whilst in rMSCs and 
coculture the increase was shifted to 7 or 14 days. Moreover, the upregulation was higher on 
F-CDHA substrate in comparison to the other CaPs, irrespective of the cell type. The
expression levels of DJ 1were higher in the two CDHA substrates compared to β-TCP. These 
levels were especially high in monocultured rEPCs and coculture at day 1 in both C-CDHA 
and F-CDHA. Subsequently, they decreased in all substrates except for rEPCs cultured on F-
CDHA. Monocultured rMSCs on C-CDHA showed also a high upregulation at day 7. 
2.6.2. Angiogenic gene expression 
The expression of angiogenic markers is depicted in Figure 7. VEGF A was overexpressed by 
cells cultured on F-CDHA at all time points, especially by rEPCs but also in the 1:2 
rEPCs:rMSCs cocultures an in the rMSC monocultures. In contrast, the cells cultured on C-
CDHA and sintered β-TCP produced similar VEGF A expression pattern: an initial peak at 
day 1, followed by a brusque decrease at days 7 and 14. The expression profile of VEGF R2 
was strongly dependent of cell type and substrate, although an overexpression was observed 
on all CaP substrates. In general, biomimetic substrates showed to cause more fluctuations in 
VEGF R2 expression rather than sintered β-TCP, which maintained similar VEGF R2 values 
over cell culture. For biomimetic CaPs, the overexpression of VEGF R2 was mainly observed 
in rEPCs monoculture presenting the highest values at days 7 and 14 for C-CDHA and F-
CDHA, respectively. The expression of EDH 1 was strongly enhanced by F-CDHA at day 1 
and 7 for rEPCs monoculture and at day 14 for coculture. In contrast, overexpression of 
EDH1 was observed in the rEPCs monoculture on β-TCP at day 14. 




































































The effect of coculture on the expression of osteogenic and angiogenic markers is presented 
in Figure 8. Upregulation of osteogenic markers in coculture condition was substrate and 
gene dependent. In general, the F-CDHA substrate led to higher values of upregulation of 
osteo-specific genes compared to other biomimetic C-CDHA and to sintered β-TCP. For F-
CDHA, the main upregulation peak of osteogenic genes was detected at day 1 or day 7 of 
coculture.  Both biomimetic C-CDHA and sintered β-TCP showed similar patterns for BMP-2, 
OC and DJ 1 showing dual upregulation peak at day 1 and 14. 
With regards to angiogenic gene expression, the cocultue of rEPCs and rMSCs resulted in 
strong upregulation of VEGF R2 and EDH 1 when the cells were cultured on F-CDHA and β-
TCP, mainly at day 14 of coculture. The expression of EDH 1 was enhanced by F-CDHA 
whilst VEGF R2 expression was upregulated by both F-CDHA and β-TCP substrates (Figure 
8). 
3. Discussion
3.1. Proliferation of rEPCs and rMSCs on the different substrates 
The proliferation of rEPCs and rMSCs was clearly affected by the substrate to different 
extents, being slower in general on the biomimetic CDHA (Figure 2A). The reduction of the 
proliferation rate was more pronounced for the rMSCs and the cocultures, particularly on F-
CDHA. This can be attributed to various factors. For instance, medium composition, surface 
topography as well as the ratio between cell types in coculture system were reported to 
influence cell proliferation.[24–26] Following previous reports, we decided to use EGM-2 MV, 
a medium for the culture of endothelial cells, both for coculture and monocultures instead of a 
mixture of cell culture media to guarantee endothelial cell survival.[21,27–29] Even if the use of 
endothelial cell culture medium for rMSCs monoculture is not a common choice, several 



































































EGM-2.[30–32] Moreover, the use of the same culture medium for all cultures is a clear 
advantage when comparing bioactive materials, which are known to interact with the cell 
culture medium. Using a single cell culture medium allows discarding any interactions due to 
the interaction of the material with the cell culture media of different compositions. 
The analysis of cell behaviour on CaP substrates requires to take into consideration not only 
their physicochemical features but also their intrinsic reactivity with aqueous environment. 
The reactive behaviour of CaPs in vitro and its further effect on bone cell behaviour, more 
pronounced for substrates with high SSA, has been widely reported.[13,33–35] For instance, we 
previously showed that CDHA altered ionic concentration to a higher extent than sintered 
ceramics[36], which can be related not only to the high SSA, but also to the presence of non-
apatitic domains on their crystal surface.[37,38] Moreover, the distinct structural features of 
chemically identical substrates used in the present study, i.e. F-CDHA and C-CDHA, might 
produce different ionic fluctuations and thereby affect the cellular behaviour to different 
extents. Another interesting issue is that expected ionic fluctuations might vary depending of 
medium composition[34,36] as well as presence or not of cells[39]. In the latter case, the layer of 
cells might reduce the exposure of the substrate to different extents depending on the degree 
of surface coverage, which in turn would decrease the ionic exchange.[40] In the current study 
we observed that CDHA substrates released Pi , and in agreement with a previous work,
[41] 
this trend was more pronounced for F-CDHA than for C-CDHA, due to its higher SSA. This 
behaviour can be associated with the incorporation of  B-type carbonate into the apatite lattice, 
replacing phosphate groups, as demonstrated in a previous study.[41]   In fact, the release of Pi
also occured in absence of cells, as displayed in Figure S2. 
Interestingly, although the monocultures and coculture on CaPs were performed using the 
same cell culture medium, the release of Pi was different in the different cultures. While the 
trends of Pi release observed for biomimetic substrates with monocultured rMSCs and 



































































release 2-fold for both F-CDHA and C-CDHA. However, since little differences of cellular 
adhesion on the biomimetic CDHA were observed at 6 hours of cell culture, the different Pi 
release cannot be explained with the hypothesis that the layer of cells might cover the surface 
of substrate reducing the ionic exchange.[40] Therefore, the different ionic behaviour observed 
in monocultured rEPCs could be attributed to the cellular activity. For instance, the 
endothelial cells exhibit the capacity to uptake Pi in hyperphosphatemia what increases the 
apoptosis rate.[42,43]
On another hand, given the calcium- defficient nature of CDHA substrates, an uptake of 
calcium from the cell culture medium triggered by the maturation of hydroxyapatite was 
expected, as proved in previous works usong other cell culture media.[41] However, little 
depletion of this ion was observed. This can be explained by the high Mg+2 content in the 
EGM-2 MV culture medium, which resulted in the uptake of this ion by the substrate, which 
likely mitigated the uptake of calcium, as shown in Figure S2. 
In our study, monocultured rEPCs showed similar proliferative potential on all CaPs with 
slightly lower proliferation rate for biomimetic substrates (Figure 2 and 3). Previous studies 
with bioinert substrates showed that topographical cues of biomaterials have little impact on 
proliferation of endothelial cells.[44] For instance, Xu et al. observed similar adhesion and 
proliferation of ECs cultured on randomly electrospun PLLA substrates with either nano- or 
micro-roughness.[44] It is important to highlight that, unlike in the case of inert materials, 
calcium phosphates control cellular behaviour also through fluid-mediated effects i.e. the 
ionic exchange with cell culture medium. For instance, the depletion of magnesium in case of 
biomimetic CDHA (Figure S2) may result in the lower proliferative potential of monocultured 
rEPCs, since this particular ion was reported to be vital in modulating endothelial cell 
behaviour.[45,46] Other possible explenation for slowed proliferation of rEPCs on these 




































































In contrast, reduced proliferation was observed for biomimetic substrates in comparison to β-
TCP in rMSCs monoculture. This might be attributed to two simultaneously affecting factors: 
the microstructure of CDHA and its intrinsic ionic reactivity. We previously demonstrated 
that ionic fluctuations caused by CDHA particularly affect rMSCs causing a reduction on the 
number of focal adhesions and cell shrinkage and leading to cell death via apoptosis.[36,41] 
Interestingly, although the F-CDHA possesses the same chemical composition as C-CDHA, it 
led to a more pronounced reduction of MSCs number. A similar behaviour was previously 
observed for osteoblastic cells.[47] The more pronounced release of Pi caused by F-CDHA due 
to its smaller crystal size and thus the higher SSA could be the responsible for this reduced 
proliferation. For instance, Liu et al. demonstrated that even small changes of Pi 
concentrations in cell culture medium reduce the proliferation of MSCs.[48] The effect of 
topography on cellular proliferation cannot be overlooked. For instance, we previously 
demonstrated that the contact of cells with topography of CaP substrate slowed down the 
proliferation rate compared to cells exposed exclusively to CaP extracts without the additional 
effect of microstructure.[36] 
Slowed cell proliferation on coculture system was also observed for CDHA, also especially 
for F-CDHA. Since the greater part of cells was constituted of rMSCs, we hypothesize that 
this behavior can be also attributed to microstructure and ionic fluctuations of CDHA as 
above described for the rMSCs monoculture. Interestingly, the PECAM-1 staining revealed 
few number of rEPCs in coculture system, irrespective of the substrate (Figure 5). The 
possible explanation of this scenario might be the growth rate of cells that might change when 
exposed to coculture conditions.[24] Bidarra et al. showed that MSCs and ECs cultured alone 
exhibited different proliferation rate as when they were cocultured. The authors observed that 
ECs stimulated the expansion of MSCs what might contribute to curtail ECs capability to 
grow in coculture. This led to lower proliferation rate for EC in coculture compared to EC in 



































































proliferative potential of ongrowth endothelial cells (OECs) when exposed to coculture 
conditions. Coculturing bone cells with OECs at ratio 3:2 lead to two opposite behaviors: 
whilst bone cells increased their number over time, a decrease was observed for OECs.[47] In 
our study, the low number of rECPs was interestingly observed in both CaPs and control 
group (Figure 5). The high proliferation rate of coculture for control group and β-TCP 
combined with low number of PECAM-1 positively stained cells suggest an increased growth 
of MSCs what might contribute to curtail effect over rEPCs (Figure 2A). Instead, the low 
cellular number of coculture observed on CDHA substrates suggests other parameters 
involved in reducing the rEPCs proliferation since this cannot be associated with increased 
rate of rMSCs proliferation. One possible explanation for this scenario might be the increased 
levels of phosphate from CDHA, since levels above 2.5 mM were reported to induce 
apoptosis in ECs.[43,50] 
3.2. Angiogenic differentiation of rEPCs and rMSCs on the different substrates 
In order to evaluate the angiogenic potential of CaPs, the expression of VEGF A and VEGF 
R2 was measured in mono- and coculture conditions (Figure 7). Additionally, cell cultures 
were subjected to the endothelial specific PECAM-1 staining to reveal wether rEPCs form 
microcapillary-like structures on CaP substrates (Figure 5). 
VEGF A plays a pivotal role in the angiogenesis process, regulating the recruitment of 
endothelial progenitor cells as well as promoting its proliferation and differentiation.[23] 
VEGF A has been also suggested to mediate the secretion of osteogenic factors such as BMP-
2, thus stimulating bone cell behaviour.[51] Interestingly, VEGF A is known to be expressed 
not only by endothelial cells, but also by pre-osteoblasts during differentiation,[52] thereby 
paracrinely stimulating angiogenesis. In our study, early VEGF A overexpression at 1 day 



































































F-CDHA (Figure 7). Whilst rEPCs cultured on C-CDHA showed a decrease of VEGF A after
1 day expression peak, rEPCs on F-CDHA sustained high values of VEGF A. Furthermore, 
VEGF A expression was also upregulated for monocultured rMSCs and coculture on F-
CDHA. This behaviour was not observed for other CaP substrates. Several authors studied the 
effect of bioactive character of substrates such as bioglasses on high expression of VEGF A in 
endothelial cells. However, they rather point the stimulatory effect of the release of calcium, 
which was not altered in our study.[53,54] On the other hand, the surface roughness also plays 
an important role in regulating angiogenic gene expression. For instance, the upregulation of 
VEGF A was observed in bioinert materials with surface roughness (Ra) of approximately 2 
μm.[55] Although the bioactive character of CDHA hinder to interrelate the enhanced VEGF A 
expression with the topography of the substrate, we hypothesize that the roughness of CDHA 
might contribute to present scenario. The expression of VEGFR2 as the main receptor and 
major mediator of the angiogenic effects of VEGF on endothelial cells[56,57] was also studied. 
We found that the enhanced expression of VEGF A from endothelial cells cultured on F-
CDHA substrate correlated with higher levels of their VEGFR2 at early time of cell culture. 
Interestingly, strongly enhanced values of VEGF A at 1 day for monocultured rEPCs on F-
CDHA (Figure 7) also corresponded in time with upregulation of EDH 1 and DJ 1 (Figure 6) 
as well as sustained expression of BMP-2 (Figure 6)- potent angiogenic inducers.[8,58] Hence, 
we hypothesize that greater expression of VEGF A might be coupled with combined effect of 
the enhanced expression of these genes as well as upregulation of VEGF R2. For instance, 
Kim et al. demonstrated a positive effect of DJ 1 on VEGF A expression in endothelial cells 
through involvement of autocrine and paracrine mechanisms.[6] 
Positively PECAM-1 stained cells were observed in both monocultured rEPCs and cocultured 
conditions (Figure 5A). Nevertheless, we did not observe capillary-like networks in any of the 
studied CaP substrate. In both mono- and coculture conditions rEPCs were present in the form 



































































3.3. Osteogenic differentiation of rEPCs and rMSCs on the different substrates 
The commitment of mono and cocultured rEPCs and rMSCs towards osteoblastic lineage was 
also evaluated through RT-qPCR. Alkaline phosphatase (ALP) expression and osteocalcin 
(OC) are commonly used markers of early and late osteogenic gene expression, respectively.  
Whilst ALP is implicated in the regulation of local concentrations of inorganic phosphates 
fostering the mineralization,[59] OC regulates the quality and size of newly-formed mineral 
crystals.[60] Since the number of rMSCs on the different substrates was relatively low during 
all the cell culture time points, we were not able to measure the ALP activity. The gene 
expression of BMP-2 and DJ 1 were also evaluated since both participate in osteogenesis 
process as well as they are potent enhancers of angiogenesis.[6,61,62] 
Different trends of expression of ALP, OC, BMP-2 and DJ 1 were observed for mono and 
coculture conditions (Figure 6). Moreover, the expression of each individual osteogenic 
marker was also time- and substrate-dependent. In general, cells cultured on CaPs materials 
showed higher gene expression at early time point compared to TCPS. This effect was 
observed for both mono- and coculture condition being more pronounced for biomimetic 
substrates. The result is coincident with other studies where stimulatory effect of CaPs on 
osteogenic expression was demonstrated.[41,63] For instance, we previously reported that 
biomimetic materials induce the differentiation of MSCs to greater extent than sintered 
ceramic.[36] This stimulatory effect is likely due to the coupled effect of subtle ionic 
fluctuations and surface topography- pivotal parameters in controlling osteogenic cell 
commitment.[64,65] The little changes of calcium content in EGM-2 MV medium after 
immersion of CDHA allowed the cell survival and further differentiation. This agrees with 
our previous finding where differentiation of MSCs into osteoblastic lineage cultured on 



































































both biomimetic CDHA own the same chemistry, the osteogenic differentiation was more 
pronounced for needle-like F-CDHA substrate suggesting the important role of surface 
topography.[47] This scenario, indeed, might contribute to curtail proliferation rate of MSCs 
(Figure 2A) inasmuch as osteogenic differentiation is usually accompanied by slower cellular 
proliferation. 
3.4. Angiogenic and osteogenic differentiation of rEPCs and rMSCs in coculture 
The impact of coculturing rEPCs with rMSCs on angio- and osteogenesis was depicted in 
Figure 8. Overall, the F-CDHA stimulated to a greater extent the gene expression in coculture 
conditions compared to rMSCs monocultured on the same substrate. Interestingly, this 
upregulation was more pronounced for osteogenic-related genes, which were upregulated 
either at 1 day (BMP-2, OC and DJ1) or 7 days (ALP and OC) (Figure 8). Regarding the 
angiogenic gene expression, there were no impact of coculturing rEPCs and rMSCs on 
upregulation of VEGF A, the main regulator of angiogenic events, on any of studied CaP 
substrates.  
The previous reports showed that there are several parameters that might orchestrate this 
behavior in coculture. For instance, Villars et al. underlined that a direct cell contact, through 
gap junctional proteins like Cx43, is a fundamental condition for stimulation of gene 
expression in endothelial and bone cells in in vitro coculture systems.[66] However, since 
monocultured and cocultured cells presented similar secretion of Cx43 (Figure 4), the 
enhanced expression of osteogenic genes for coculture on F-CDHA should be attributed to 
other events that orchestrate this behavior. The great influence of potent osteogenic enhancers 
like BMP-2, EDH 1 and DJ 1 was also mentioned in literature. Kaigler et al. demonstrated 
that direct cell-cell contact mediate BMP-2 signaling from endothelial cells enhancing the 



































































associated only with angiogenic events, was also reported to stimulate differentiation of 
osteoprogenitor cells.[23] Moreover, previous reports demonstrated that DJ 1 not only mediates 
the endothelial- bone cells’ crosstalk but also induces osteogenesis through FGFR-1 
signaling.[6] Since no enhanced expression of BMP-2 and EDH 1 in coculture was observed 
for F-CDHA substrate we hypothesize that the higher levels of DJ 1 might contribute to the 
osteogenic potential of F-CDHA. 
4. Conclusion
The results demonstrate that distinct chemical features of CaPs substrate trigger various cell 
responses in terms of proliferation as well as angiogenic and osteogenic gene expression. In 
general, ionically more reactive CDHA affect proliferation rate to greater extent than sintered 
β-TCP. The F-CDHA led to more pronounced ionic changes than C-CDHA significantly 
reducing proliferation rate of rMSCs and the coculture of rECPs: rMSCs. For β-TCP, where 
cells were exposed to little ionic exchange, the coculture resulted in enhanced growth of 
rMSCs compared to monocultured rMSCs. 
With regards to coculture condition, the cellular crosstalk was not reflected in enhanced 
secretion of gap junctional protein Cx43 but through upregulation of osteogenic-related genes. 
This behavior was mainly observed for F-CDHA substrate and might be related to enhanced 
expression of osteogenic inducer DJ 1. 
5. Experimental Section
Determination of coculture ratio of rEPCs and rMSCs: For the coculture studies, both cell 
types were expanded separately in their corresponding cell culture media till 70-80% of 
confluence. Afterwards, rEPCs and rMSCs were detached and seeded at rEPCs:rMSCs ratios 



































































EGM-2 MV medium at 37 oC in a humidified 5% CO2 incubator replacing the medium every 
other day. The optimum ratio for coculture conditions was chosen evaluating cell proliferation, 
cell differentiation, and cell mineralization. The details regarding methods applied for 
quantification of cellular behaviour in coculture conditios were provided in Supplementary 
Information. 
Material preparation: CDHA was obtained by hydrolysis of α- tricalcium phosphate (α-TCP) 
via a cementitious reaction, as previously described.[68] Briefly, α-TCP powder was prepared 
by heating at 1400°C for 15 h a  2:1 molar mixture of calcium hydrogen phosphate (CaHPO4, 
Sigma-Aldrich, St. Louis, USA) and calcium carbonate (CaCO3, Sigma-Aldrich, St. Louis, 
USA), followed by quenching in air. α-TCP powders with two different sizes were obtained 
by milling according to two different protocols. The α-TCP powder with larger size (coarse, 
C: 5.2µm median size) was obtained my milling in agate ball mill (Pulverisette 6, Fritsch 
GmbB) with 10 balls (d=30 mm) for 15 min at 450 rpm. The α-TCP powder with smaller size 
(fine, F: 2.8 µm) was first milled with 10 balls (d=30 mm) for 60 min at 450 rpm  followed by 
second milling with 10 balls (d=30 mm) for 40 min at 500 rpm and the third one with 100 
balls (d=10 mm) for 60 min at 500 rpm.[69]  
CDHA discs were obtained by mixing a solid phase consisting of α-TCP powder and 2 wt.% 
of precipitated hydroxyapatite (PHA; Merck 2143, Merck, Darmstardt, Germany) with a 
liquid phase of 2.5 wt.% disodium hydrogen phosphate (Na2HPO4, Merck, Darmstadt, 
Germany), with a liquid to powder ratio of 0.35 mL g-1. The paste was transferred to Teflon 
moulds (15 mm diameter and 2 mm thickness) and immersed in water at 37 oC for 7 days for 
complete reaction. The products obtained were coded as C-CDHA or F-CDHA depending on 
the size of the starting powder. 
β-tricalcium phosphate discs were obtained by sintering C-CDHA at 1100oC for 15 hours, 



































































Material characterization: Phase composition of the different CaPs was assessed by X-ray 
diffraction (XRD, D8 Advance, Brucker, Karlsruhe, Germany). The diffractometer equipped 
with a Cu Kα X-ray anode was operated at 40 kV and 40 mA. The data was collected in 0.02° 
steps over the 2θ range of 10°-80° with a counting time of 4s per step. The phases were 
identified by comparison to the diffraction patterns of HA (JCPDS 82-1943), α-TCP (JCPDS 
09-0348) and β-TCP (JCPDS 70-2065). Semiquantitative XRD analysis of the products was
carried out using the reference intensity ratio method.[70] The microstructure of materials was 
analyzed by Scanning Electron Microscopy (SEM, Zeiss Neon 40, Oberkochen, Germany) at 
an acceleration voltage of 5 kV. To impart conductivity, surfaces were coated with gold- 
palladium layer prior to imaging. The surface roughness was characterized by optical 
interferometry (Veeco Wyko NT1100), using a 50x magnification and a scanned area of 47.5 
x 63.4 μm2. Images were acquired using Vision32 software. The SSA and porosity of 
materials used in current study was described in previous reports.[71] 
Cell culture study: The protocol of isolation of rat mesenchymal stem cells (rMSCs) and rat 
endothelial progenitor cells (rEPCs) was described elsewhere.[72] Briefly, cells were obtained 
from the tibias and femurs of Lewis rats at the Institute for Bioengineering of Catalonia 
(IBEC). Flow cytometry was performed in order to assess cell phenotype.[73] 
rMSCs were grown in Advanced Dulbecco’s Modified Eagle Medium (AdvDMEM) 
supplemented with 10% of foetal bovine serum (FBS), 2 mM L-glutamine, 
penicillin/streptomycin (50 U mL-1 and 50 µg mL-1, respectively) and 20mM  4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer, provided from Invitrogen. 
 rEPCs were expanded in microvascular endothelial cell medium 2 (EGM2-MV, Lonza) 
containing endothelial cell basal medium (EBM-2, Lonza) supplemented with EGM-2 bullet 
kit and 5% FBS. 
All experiments, except where stated, were performed with a seeding density of 12 ×103 cells 



































































Monoculture and coculture of rEPCs and rMSCs on CaPs: C-CDHA, F-CDHA and β-TCP 
discs (12-15 mm of diameter, 2 mm of height) were sterilised with 70% ethanol, rinsed with 
PBS and pre- incubated overnight with complete EGM-2 MV medium at 37 oC. Subsequently 
the corresponding cells were seeded on the substrates. The ratio 1:2 was used for coculture 
condition on discs considering the results obtained in the previous study.  For both 
coculture[64] and monoculture of rEPCs and rMSCs,[31] EGM-2 MV medium was used. In all 
assays, the medium was refreshed after 6 hours of cell adhesion and then every other day 
throughout the whole culture period. Tissue culture polystyrene (TCPS) was used as 
corresponding control for each culture/co-culture condition. Cell number was evaluated at 6 
hours, 3, 7, 14 and 21 days by measuring LDH activity following the previously detailed 
protocol (See Supporting Information). In order to express the absorbances’ values as a cell 
number, individual calibration curves with a decreasing number of cells was prepared for each 
condtion i.e. rEPCs monoculture, rMSCs monoculture and 1:2 rEPCs:rMSCs coculture. For 
cells cultured on CaPs discs, results were normalised versus the area of the discs and then 
expressed as relative fold to TCPS at 6h. 
Ionic concentration of cell culture media: At specific time points, the supernatants from 
mono- and cocultures on CaPs were collected and stored at -20 oC for further analysis. 
Subsequently, the concentration of calcium and phosphorus were determined. The Ca2+ was 
quantified applying o- cresolphthalein complexone method.[74,75] The concentration of Pi was 
evaluated by Phosphate Colorimetric Assay Kit (Sigma- Aldrich) measuring the absorbance at 
650 nm with Synergy HTX multi-mode microplate reader (Bio-Tek Instruments, Inc.). The 
changes in concentrations of calcium and phosphate for CaP substrates immersed in EGM-2 
MV medium was also monitored without presence of cells up to 14 days. Since CDHA might 
also uptake other ions[41], the content of magnesium was additionally determined through 



































































Agilent). Prior to quantification, the supernatants was diluted 20-fold with 2% of ultrapure 
nitric acid (Sigma-Aldrich). 
Immunostaining: Monocultured rEPCs, rMSCs and coculture were stained for nuclei, F-actin 
and Connexin43 (Cx43). Monocultured rEPCs and coculture were additionally incubated with 
endothelial specific platelet endothelial cell adhesion molecule (PECAM-1, CD31). The 
staining was performed at 14 days and 21 days of cell culture. The samples were rinsed with 
PBS (x3) and cells were fixed with 4% (v/v) PFA solution in PBS. Afterwards, the 
permeablization process was carried out with 0.1 % Triton X- 100 (Sigma-Aldrich) in PBS 
during 15 min. Subsequently, cells were incubated 30 min at RT with blocking solution 
consisting of 1% bovine serum albumin (BSA) (Sigma-Aldrich) in PBS. The discs were 
incubated with the primary antibody rabbit anti- PECAM-1 (Santa Cruz Biotechnologies) at 
1:100 in 1% BSA in PBS for one hour. The step was followed by incubation with secondary 
antibody Alexa Fluor 488 chicken anti- rabbit (1:1000) and Alexa Fluor 546 Phalloidin 
(1:300) in 0.1% Triton X- 100 in PBS (all from Invitrogen). For nuclei staining, 4',6-
diamidino-2-phenylindole (DAPI) (1:1000 in 0.15% glycine in PBS)  was added and samples 
were incubated for 2 minutes.  Between all steps, three rinses for 5 minutes with 0.15% 
glycine (Sigma-Aldrich) in PBS were performed. For Cx43 staining the manufacturer 
instructions was followed in terms of cell fixation, dilution and incubation times. The primary 
antibody was mouse-anti Connexin43 C terminus (Millipore) and the secondary antibody was 
Alexa Fluor 488 goat anti- mouse (Invitrogen). The cells seeded on glass coverslip were used 
as a control group. Samples were mounted with Mowiol 4-88 (Sigma- Aldrich) and visualised 
using inverted LSM 800 ZEISS confocal microscope (CLSM). Images were acquired using 
LASX software and processed using Fiji/Image-J package. 
Angiogenic ans osteogenic gene expression of cocultured rEPCs and rMSCs on CaPs: 
Angiogenic and osteogenic gene expression was evaluated at 1, 7 and 14 days of mono- and 



































































extracted from mono and cocultures at the given time points  using RNeasy® Mini Kit 
(Qiagen, Hilden, Germany) as recommended by the manufacturer. Total RNA quantity was 
determined by NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Montchanin, 
DE, USA) and subsequently 130 ng of the total RNA were used as template for single strand 
complementary DNA (cDNA) synthesis using QuantiTect Reverse Transcription Kit (Qiagen). 
Quantitative real-time PCR (RT- qPCR) assays were performed and monitored in triplicate 
using a StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). 
The cDNA template was amplified with the QuantiTect SYBR Green RT-PCR Kit (Qiagen) 
and specific primers for angiogenic and osteogenic markers (Listed in Table S1). No-RNA 
control, the melt curve analysis and no-RT control were run to ensure the specificity of 
primers and the absence of genomic DNA, respectively. The expression of all studied genes 
were normalized by expression of  β-actin (ACTB) and relative fold changes (FC) were 
related to 1 day gene expression value of either rEPCs monocultured on TCPS with EGM-2 
MV (for angiogenesis markers: VEGF A, VEGF R2, endothelin-1) or rMSCs monocultured 
on TCPS with advDMEM (for osteogenic markers: ALP, BMP-2, OC, DJ 1). The fold change 
was calculated with the formula 
FC = Etarget 
ΔCq target (TCPS 6h – sample)/Ereference
ΔCq reference (TCPS 6h – sample). (1) 
Cq respresents the median value of the quantification cycle of the triplicate of each sample. E 
corresponds to the efficiency of amplification and is determined through following formula 
E = 10[−1/slope] where slope value proceeds from slope of the log-linear portion of the 
calibration-curve. 
Statistical analysis: Each experiment was performed in two independent runs except for the 
immunostaining and ionic content without presence of cells for which one experiment was 



































































gene expression data were plotted as means ± SE with n=6. PECAM1 area was plotted as 
means ± SE with n=10. Normality was checked through the Saphiro–Wilk test. Statistical 
significance was determined by ANOVA with Tukey HSD post-hoc analysis. Non-parametric 
data was additionally subjected to Kruskal Wallis test followed by multiple pairwise 
comparison.  Significance level for all tests was set for p < 0.05. Statistical analysis were 
performed using SPSS 23.0 software (SPSS, ICN., Chicago, IL).  
Supporting Information 
Supporting Information is available from the Wiley Online Library or from the author. 
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Figure 1. Physicochemical characterization of CaPs A) SEM micrographs of surface 
morphology. Scale bare denotes 2 μm. B) Optical interferometry images of C-CDHA, F-
CDHA and β-TCP. C) XRD patterns of the different calcium phosphate substrates. The 
vertical lines represent the patterns of HA (JCPDS 82-1943), α-TCP (JCPDS 09-0348) and β-
TCP (JCPDS 70-2065) from the Joint Committee on powder Diffraction Standards. D) Values 



































































Figure 2. A) Proliferation of monocultured rEPCs, monocultured rMCSs and cocultured cells 
with ratio 1:2 of rEPCs and rMSCs on various CaPs. Cell numbers were quantified at 6 hours, 
3 days, 7 days, 14 days and 21 days (n=6). The values were expressed as relative fold change 
compared to cell number obtained on corresponding TCPS at 6 hours. In all graphs, the same 
letter (a, b or c) indicate groups with no statistically significant differences (p > 0.05) at 
specific time point. B) Calcium concentration in EGM-2 MV medium in presence of cells 



































































Figure 3. Merged fluorescence images of monocultured rEPCs, monocultured rMSCs and 
cocultured cells with ratio 1:2 of rEPCs and rMSCs on various CaPs. Cells were stained for F-
actin (red) and nuclei (blue). The images were acquired at 14 days and 21 days of cell culture. 



































































Figure 4. Merged fluorescence images of monocultured rEPCs, monocultured rMSCs and 
cocultured cells with ratio 1:2 of rEPCs and rMSCs on C-CDHA, F-CDHA and β-TCP at 14 
and 21 days of cell culture. Cells were stained for Connexin43 (green), F-actin (red) and 



































































Figure 5. A) Merged fluorescence images of monocultured rEPCs and cocultured cells at 
ratio 1:2 of rEPCs and rMSCs on C-CDHA, F-CDHA and β-TCP at 14 and 21 days of cell 
culture. Cells were stained for PECAM-1 (green) and nuclei (blue). For coculture images, 
cells stained with both PECAM-1 and nuclei correspond to rEPCs whilst cells without 
PECAM-1 staining represent rMSCs. Scale bar denotes 200 μm for the main images and 50 
μm for magnified images. B) Semiquantitative evaluation of area of PECAM-1 staining in 
monoculutred rEPCs on CaPs at 14 and 21 days (n=10). C) Semiquantitative evaluation of the 
area of PECAM-1 staining in cocultured 1:2 rEPCs and rMSCs on CaPs at 14 and 21 days 
(n=10). In graphs B and C, the same letter indicates groups with no statistically significant 



































































Figure 6. Gene expression of osteogenic markers in monocultured rEPCs, monocultured 
rMSCs and coculture on three calcium phosphate substrates (n=6). Expressions levels were 
determined by quantitative real time RT-PCR, normalised versus monocultured rMSCs on 
TCPS at 1 day and displayed relative to their housekeeping gene. In all graphs, the same letter 
(a, b, c or d) indicates no statistically significant differences (p > 0.05) between substrates for 



































































coculture). The same number (1, 2 or 3) indicates no statistically significant differences (p > 
0.05) between cell culture conditions for each substrate (C-CDHA, F-CDHA, β-TCP, TCPS). 
Figure 7. Gene expression of angiogenic markers in monocultured rEPCs, monocultured 
rMSCs and coculture on three calcium phosphate substrates (n=6). Expressions levels were 
determined by quantitative real time RT-PCR, normalised versus monocultured rEPCs on 
TCPS at 1 day. and displayed relative to their housekeeping gene. In all graphs, the same 
letter (a, b, c or d) indicates no statistically significant differences (p > 0.05) between 
substrates for each specific cell culture condition (rEPCs monoculture, rMSCs monoculture, 
rEPCs: rMSCs coculture). The same number (1, 2 or 3) indicates no statistically significant 




































































Figure 8. A) Effect of culturing both rEPCS and rMSCs on the gene expression of 
osteogenesis and angiogenesis related genes compared to monocultured cells (n=6). In order 
to see either specific gene is upregulated in coculture system the gene expression was 
normalised versus gene expression in monocultured rMSCs or monocultured rEPCs for 
osteogenic (ALP, BMP-2, OC, DJ 1) or angiogenic (VEGF A, VEGF R2, EDH 1) genes, 
respectively. For samples where gene expression in monoculture was not detected the mean 
value obtained in coculture was plotted (*). In all graphs, the same letter (a, b, c or d) 
indicates no statistically significant differences (p > 0.05) between substrates for each specific 



































































Click here to access/download
Supporting Information
Sadowska AHM Supporting information.docx
  
Production Data
Click here to access/download
Production Data
Sadowska AHM fv manuscript-production data.doc
  
Short summary
Click here to access/download
Production Data
Sadowska AHM summary and ToC.docx
  
Table of contents
Click here to access/download
Production Data
Sadowska AHM Table of contents.tif
  
Supporting Information
Click here to access/download
Production Data







































Click here to access/download
Production Data
FIGURE 8.tif
